These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22837089)

  • 1. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
    Osazuwa OF; Dirisu O; Okuonghae E
    Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.
    Osazuwa F; Dirisu JO; Okuonghae PE; Ugbebor O
    Oman Med J; 2012 May; 27(3):228-31. PubMed ID: 22811773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
    Beyene T; Woldeamanuel Y; Asrat D; Ayana G; Boulware DR
    PLoS One; 2013; 8(10):e75585. PubMed ID: 24124498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
    Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
    Pongsai P; Atamasirikul K; Sungkanuparph S
    J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic Cryptococcal Antigenemia in People Living with HIV (PLHIV) with Severe Immunosuppression: Is Routine CrAg Screening Indicated in India?
    Anuradha S; H AN; Dewan R; Kaur R; Rajeshwari K
    J Assoc Physicians India; 2017 Apr; 65(4):14-17. PubMed ID: 28527158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
    Reepalu A; Balcha TT; Yitbarek T; Jarso G; Sturegård E; Björkman P
    BMC Res Notes; 2015 Nov; 8():702. PubMed ID: 26597840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal antigenemia and associated risk factors among ART-naïve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia.
    Hailu K; Niguse S; Hagos K; Abdulkader M
    Microbiologyopen; 2019 Jun; 8(6):e00746. PubMed ID: 30277315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
    McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
    Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
    Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
    Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans seropositivity and some haematological parameters in HIV seropositive subjects.
    Chukwuanukwu RC; Uchenna N; Mbagwu SI; Chukwuanukwu TO; Charles O
    J Infect Public Health; 2020 Jul; 13(7):1042-1046. PubMed ID: 31831399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
    Meya DB; Kiragga AN; Nalintya E; Morawski BM; Rajasingham R; Park BJ; Mubiru A; Kaplan JE; Manabe YC; Boulware DR
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):182-189. PubMed ID: 30399034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy-Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana.
    Hurt WJ; Tenforde MW; Molefi M; Mitchell HK; Milton T; Azama MS; Goercke I; Mulenga F; Tlhako N; Tsholo K; Srivastava T; Leeme TB; Simoonga G; Muthoga C; Lechiile K; Mine M; Jarvis JN
    Clin Infect Dis; 2021 May; 72(10):1745-1754. PubMed ID: 32236414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
    Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
    PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.